# Contact — Thymosin Alpha-1 Reviews (Review TA1 Editorial Desk)

> Contact the Review TA1 editorial desk about the Thymosin Alpha-1 digest — corrections and citation queries on the thymic-peptide literature. Not a clinic; no medical advice or product sales.

For corrections, citation questions, and editorial queries about the published record.

## Reach the editorial desk

Review TA1 welcomes corrections and citation queries about its Thymosin Alpha-1 coverage. If a study has been characterized imprecisely, or a newer paper should be weighed into the record, the desk wants to know. We are an editorial project, not a healthcare provider: we cannot answer questions about personal health, dosing, sourcing, or treatment, and we do not provide medical advice. For anything clinical, please consult a qualified professional.

## Send a message

Use the form below to reach the desk. Please include the page and the reference number in question where relevant, and a citation if you are proposing a correction or addition. We read every message about the literature; we do not respond to product, sourcing, or purchase inquiries, as nothing here is for sale.

- **Name** — who is writing
- **Email** — where a reply should go
- **Page / reference** — the page and [N] marker your note concerns
- **Message** — your correction, citation, or editorial query

## What we cannot help with

We cannot advise on whether anyone should use Thymosin Alpha-1, how much to use, where to obtain it, or how it might interact with a medical condition or medication. Those are clinical questions for a licensed professional. This desk handles the published science only — the accuracy of what we have reported and the completeness of the references behind it.

---

A register of record on the thymic immune peptide thymosin alpha-1 — every claim logged to its study, the largest sepsis trial's null result kept in plain view, and not one thing here a clinic, a prescription, or for sale.